Source:http://linkedlifedata.com/resource/pubmed/id/19498430
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-6-5
|
pubmed:abstractText |
Investigators in Germany have solicited the views of neurologists and psychiatrists on the effectiveness of antidementia drug treatments. The study concludes that clinicians generally consider these treatments to be beneficial, and that the provision of support to caregivers seems to further enhance the perceived benefits.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1759-4766
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
302-3
|
pubmed:meshHeading |
pubmed-meshheading:19498430-Alzheimer Disease,
pubmed-meshheading:19498430-Cholinesterase Inhibitors,
pubmed-meshheading:19498430-Dementia,
pubmed-meshheading:19498430-Humans,
pubmed-meshheading:19498430-Neurology,
pubmed-meshheading:19498430-Outcome Assessment (Health Care),
pubmed-meshheading:19498430-Psychiatry
|
pubmed:year |
2009
|
pubmed:articleTitle |
Alzheimer disease: Perceived efficacy of antidementia drug treatment.
|
pubmed:affiliation |
University of Manchester Psychiatry Research Group, University Place, Oxford Road, Manchester, UK.
|
pubmed:publicationType |
Journal Article,
Comment
|